Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Grodzisk Mazowiecki – page 3

33 clinical trials in Grodzisk Mazowiecki, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Grodzisk Mazowiecki at a glance
33
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

33 trials in Grodzisk Mazowiecki

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tovinontrine
  • Sponsor:Cardurion Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tovinontrine
  • Sponsor:Cardurion Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Diroximel Fumarate
  • Sponsor:Biogen Idec Research Limited

Cardiac failure+4

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cdr132L
  • Sponsor:Cardior Pharmaceuticals GmbH

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Grodzisk Mazowiecki

What the registry says about research in the country

01 Cardiovascular Research

Advanced clinical trials exploring treatments for atherosclerotic cardiovascular disease and stroke prevention. Studies focus on innovative therapies for heart failure and post-myocardial infarction care.

  • Stroke Prevention Therapies
  • Heart Failure Management
  • Atrial Fibrillation Treatments

Researchers are evaluating novel compounds like asundexian and obicetrapib for improving cardiovascular outcomes.

02 Autoimmune Conditions

Comprehensive studies investigating treatments for various autoimmune disorders, including psoriatic arthritis and multiple sclerosis. Research focuses on targeted therapies and disease-modifying treatments.

  • Psoriasis Management
  • Multiple Sclerosis Therapeutics
  • Sjögren's Disease Treatment

Novel biologics and immunomodulators are being tested to improve patient outcomes.

03 Respiratory Medicine

Innovative research into treatments for chronic obstructive pulmonary disease, examining new therapeutic approaches for managing moderate to severe cases.

  • COPD Exacerbation Prevention
  • Advanced Respiratory Therapeutics
  • Pulmonary Function Enhancement

Studies evaluate medications like tezepelumab and benralizumab for improving respiratory outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.